Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.3.0.814
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Income Statement [Abstract]        
Sales $ 72,000 $ 139,980 $ 177,459
Operating Expenses        
Selling, general and administrative 1,789,435 $ 797,195 2,758,245 2,521,695
Research and development 1,745,981 895,669 2,618,215 2,364,686
Total operating expenses 3,535,416 1,692,864 5,376,461 4,886,381
Interest expense, net 329,692 95,001 437,919 251,978
Net loss during the development stage $ (3,793,108) $ (1,787,865) $ (5,674,400) $ (4,960,900)
Basic and diluted loss per share $ (0.02) $ (0.01) $ (0.04) $ (0.03)
Weighted average number of common shares outstanding 158,172,668 146,897,008 158,172,668 146,897,008